HCPLive

AUGUST 31, 2024

RESHAPE-HF2 shows mitral transcatheter edge-to-edge repair (M-TEER) reduces heart failure hospitalizations and improves quality of life vs optimal medical therapy alone.

Quality of Life 64

Quality of Life Bicuspid/Mitral Heart Failure Hospital 64

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

IntroductionHeart failure (HF) causes high symptom burden and shortens life expectancy. Implementation of Palliative Care (PC) concurrently with cardiologic guidelines-directed medical therapy (GDMT) improves quality-of-life (QoL) more than disease-oriented management alone but is underused.

Quality of Life 52

Quality of Life Heart Failure Research Outcomes 52

Frontiers in Cardiovascular Medicine

MARCH 16, 2025

We hope to identify high-risk patients for early intervention to reduce the incidence of HF and improve their quality of life. This online forecasting tool not only processes a large amount of data but also continuously optimizes and adjusts the accuracy of the model according to the latest medical research and clinical data.

Heart Failure 52

Heart Failure Quality of Life Risk Factors Cardiovascular Disease 52

DAIC

APRIL 6, 2024

The trial, called RELIEVE-HF , is the first randomized placebo-procedure controlled trial of interatrial shunting that included patients with both major types of heart failure : heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Heart Failure 75

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 75

DAIC

MAY 28, 2024

milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).

Heart Failure 98

Heart Failure Quality of Life Research Blood Pressure 98

American College of Cardiology

NOVEMBER 16, 2024

In patients with obesity and heart failure with preserved ejection fraction (HFpEF), weekly treatment with tirzepatide over approximately two years reduced the risk of worsening heart failure events, based on findings from the SUMMIT trial.

Preserved Ejection Fraction 75

Preserved Ejection Fraction Quality of Life Obesity Heart Failure 75

Becker's Hospital Review - Cardiology

JULY 9, 2024

New study finds strict sodium restrictions may not benefit heart failure patients. per day can improve quality of life Moderate salt intake of 3.0-4.5g

Heart Failure 69

Heart Failure Quality of Life 69

Science Daily - Heart Disease

AUGUST 30, 2024

In the ABYSS trial, the cardiovascular safety of interrupting beta-blocker could not be shown in comparison with beta-blocker continuation and beta-blocker interruption did not improve quality of life.

Heart Attack 130

Heart Attack Heart attacks Quality of Life Myocardial Infarction 130

CardiacWire

FEBRUARY 19, 2025

Although heart failure prognosis is grim, the ALT-FLOW trials two year results suggest that diverting blood from the left atrium to the coronary sinus using a shunt could have lasting benefits for patients with HFmrEF/HFpEF.

Quality of Life 59

Quality of Life Heart Failure Blood Pressure Hospital 59

DAIC

APRIL 6, 2024

The trial, called RELIEVE-HF , is the first randomized placebo-procedure controlled trial of interatrial shunting that included patients with both major types of heart failure : heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

Frontiers in Cardiovascular Medicine

JANUARY 21, 2025

It can be associated with reduced quality of life and complications such as heart failure and stroke. Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. Pulmonary vein isolation (PVI) is the most effective treatment for rhythm control.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Ablation Electrophysiology 52

DAIC

FEBRUARY 12, 2024

Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors — natural sensors located in the wall of the carotid artery, according to CVRx. I felt weak and tired all the time and knew I didn’t want to spend my life sitting in the living room chair. and Allina Health.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart Attack 104

European Journal of Heart Failure

DECEMBER 22, 2023

Abstract Right-sided heart failure and tricuspid regurgitation are common and strongly associated with poor quality of life and an increased risk of heart failure hospitalizations and death. This article is protected by copyright. All rights reserved.

Heart Failure 75

Heart Failure Tricuspid Cardiovascular Interventions Quality of Life 75

Dr. Paddy Barrett

NOVEMBER 1, 2024

Death from heart disease: 51% reduction in risk. Heart Failure: 69% reduction in risk. The key point here is that not only do high levels of fitness make you likely to live longer, but it is also one of the best ways of improving your healthspan and quality of life as you age. Cancer deaths: 43% reduction in risk.

Exercise 119

Exercise Heart Disease Quality of Life Blood Pressure 119

European Journal of Heart Failure

NOVEMBER 29, 2023

ABSTRACT Aims Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

European Journal of Heart Failure

DECEMBER 13, 2023

ABSTRACT Aim Chronic obstructive pulmonary disease (COPD) is common in heart failure with a mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and is associated with worse outcomes. The primary outcome was a composite of cardiovascular death or worsening heart failure. 0.93]; COPD: HR 0.82 [95% CI 0.62–1.10];

Preserved Ejection Fraction 75

Preserved Ejection Fraction Heart Failure Pulmonary Quality of Life 75

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

At present, the main methods to treat ischemic heart disease are drug therapy, intervention and operation. These methods only alleviate symptoms of heart failure and myocardial ischemia and improve patients' quality of life by partially restoring myocardial reperfusion.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

DAIC

FEBRUARY 15, 2024

(AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF). It is estimated that 26 million worldwide are living with congestive heart failure.

Heart Failure 89

Heart Failure Cardiomyopathy Quality of Life Innovation 89

American College of Cardiology

OCTOBER 1, 2024

Guideline-directed medical therapy (GDMT) is essential for managing heart failure with reduced ejection fraction (HFrEF).

Heart Failure 61

Heart Failure Quality of Life Article 61

HCPLive

MARCH 14, 2024

The AccuCinch® System, utilized by Allegheny General Hospital, offers a breakthrough approach to treating heart failure by targeting the left ventricle.

Quality of Life 52

Quality of Life Heart Failure Cardiac Function Innovation 52

DAIC

APRIL 22, 2024

RELIEVE-HF failed to meet its primary efficacy endpoint and did not reduce heart failure events or improve quality of life in heart failure patients with a preserved ejection fraction (HFpEF). For more information: www.corviamedical.com If you enjoy this content, please share it with a colleague

Preserved Ejection Fraction 105

Preserved Ejection Fraction Quality of Life Heart Failure Pacemaker 105

DAIC

FEBRUARY 18, 2025

Studies estimate that severe regurgitation occurs in up to 4% of individuals 75 and older and is often linked with conditions like heart failure, atrial fibrillation or pulmonary hypertension. We prioritize improving quality of life, particularly for patients experiencing severe fatigue and breathlessness.

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

DAIC

APRIL 16, 2024

a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. The manuscript is available online at the European Journal of Heart Failure website.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

American College of Cardiology

AUGUST 2, 2024

Iron deficiency (ID) is a common comorbidity among patients with heart failure (HF), and it is associated with reduced exercise tolerance and quality of life and serves as a marker of increased risk of hospitalizations and mortality.

Heart Failure 45

Heart Failure Quality of Life Exercise Hospital 45

DAIC

MARCH 25, 2025

Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Open Heart

JUNE 9, 2022

Background This review aimed to compare the relative effectiveness of different exercise-based cardiac rehabilitation (ExCR) delivery modes (centre-based, home-based, hybrid and technology-enabled ExCR) on key heart failure (HF) outcomes: exercise capacity, health-related quality of life (HRQoL), HF-related hospitalisation and HF-related mortality.

Quality of Life 52

Quality of Life Cardiac Rehabilitation Exercise Heart Failure 52

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

Heart failure (HF) is recognized as an epidemic in the contemporary world, impacting around 1%–2% of the adult population and affecting around 6 million Americans. HF remains a major cause of mortality, morbidity, and poor quality of life.

Heart Failure 64

Heart Failure Electrophysiology Quality of Life Arrhythmia 64

European Journal of Heart Failure

MARCH 11, 2024

This study found that treatment with sodium–glucose cotransporter 2 (SGLT2) inhibitors in patients with heart failure and reduced ejection fractions (HFrEF) was associated with lower skeletal muscle pathology. Muscle biopsies were collected from patients treated with SGLT2 inhibitors (>12 months) and compared to untreated controls.

Heart Failure 75

Heart Failure Quality of Life Outcomes Research 75

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have emerged as major age-related epidemics within cardiology. Indeed, these two conditions are commonly found in the same individual, so much so that AF has been used in proposed diagnostic criteria for HFpEF.

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Electrophysiology 59

DAIC

FEBRUARY 21, 2024

However, there is a notable gap in device options for infants and young children with end stage heart failure. Although tools for the youngest heart patients are limited, the Ochsner Children’s Hospital team provides top-of-the-line care to bridge patients safely to transplant and a hope for a better quality of life.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

JULY 11, 2024

Heart failure (HF) is a growing worldwide public health issue affecting 64 million people annually 1 and is associated with high mortality, lower quality of life and reduced physical capacity while placing substantial costs on the healthcare system.

Heart Dysfunction 109

Heart Dysfunction Quality of Life Heart Failure Public Health 109

American College of Cardiology

JANUARY 6, 2025

In this episode, Andrea Price, MS, AACC hosts Jae Patton, MSN, CRNP, AACC and Sarah Godfrey, MD, MPH to share insights for ensuring quality of life when time is short: tools for the end-stage heart failure care.

Heart Failure 49

Heart Failure Quality of Life Heart Disease Article 49

Medical Xpress - Cardiology

MARCH 17, 2025

Heart failure is a major health concern, especially for aging populationsit significantly increases mortality rates, and severely impacts quality of life of those affected. Exercise therapy has been shown to be particularly effective for patients with heart failure.

Heart Failure 40

Heart Failure Exercise Quality of Life Hospital 40

Heart BMJ

MARCH 26, 2025

This study aimed to evaluate the cost-effectiveness of digoxin versus beta-blockers for heart rate control in patients with permanent AF and symptoms of heart failure. Background Atrial fibrillation (AF) is a major and increasing burden on health services.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Heart Failure 40

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Background Exercise training is commonly employed as a efficacious supplementary treatment for individuals suffering from heart failure, but the optimal exercise regimen is still controversial. 41.70), and Minnesota Living with Heart Failure Questionnaire (MD = −4.45, 95% CI for −6.25 to −2.64) compared to MICT.

Heart Failure 64

Heart Failure Exercise Quality of Life Cardiac Function 64

Circulation: Heart Failure

JANUARY 8, 2025

Circulation: Heart Failure, Ahead of Print. Compared with cold and wet patients, cold and dry patients also had better baseline functional capacity and quality of life and experienced milder improvements after LVAD: EuroQol (+0.11 versus +0.17;P=0.001),

Quality of Life 76

Quality of Life Heart Failure Pulmonary Cardiomyopathy 76